Trends in Pharma

Personalized medicine is transforming healthcare by tailoring treatments to individual patients. Big data and virtual advisory boards are key enablers, but challenges like data privacy and ethical considerations must be addressed.

Trends in Pharma

The pharmaceutical industry is undergoing rapid transformation in 2024, driven by AI, virtual platforms, telehealth, RWE, and sustainability. These trends are reshaping drug discovery, patient care, and industry practices.

Education

Digital CME platforms have revolutionized medical education by providing accessible, interactive, and sustainable learning experiences. This article explores how these platforms facilitate global collaboration and knowledge sharing, while also reducing costs and environmental impact.

Trends in Pharma

The healthcare industry has increasingly recognized the importance of a patient-centric approach. This article explores the evolution towards patient-centricity promises to enhance patient outcomes, boost treatment adherence, and elevate overall patient satisfaction.

Trends in Pharma

The article highlights the crucial role of medical affairs in promoting ecological sustainability in the pharmaceutical industry. By implementing sustainable initiatives, medical affairs have united healthcare providers environmental experts to develop eco-friendly initiatives and foster global collaboration through virtual platforms.

Trends in Pharma

This article explores how the global pharmaceutical industry embraces sustainable practices and reduces unnecessary travel. Leading pharmaceutical companies are committing to greener initiatives, such as minimizing travel to align with global sustainability goals.

Trends in Pharma

This article underscores the importance of understanding disease ecosystems in R&D and Medical Affairs. This article provides valuable data for understanding the significance of disease ecosystems and their requisite role in shaping the trajectory of medical and patient care advancements in the domains of research and development and Medical Affairs.

Trends in Pharma

This article delves into the transformation of MSLs into ISLs in the pharmaceutical realm, highlighting their shift from information providers to pivotal players in clinical trials. Discover how MphaR's interactive training program prepares MSLs for this transition, equipping them with the necessary expertise to navigate complex trial landscapes.

Trends in Pharma

The article explores the impactful role of small companies in global health through virtual initiatives. It also emphasizes how virtual platforms reduce barriers to education, allowing medical professionals worldwide to access educational materials.

Trends in Pharma

This article will make a comprehensive dive into the transformation of MSLs, understanding how they have adapted to implement the demands of today's healthcare infrastructure while contributing towards the consistent improvement in patient care. 

Trends in Pharma

Explore how the COVID-19 pandemic has accelerated pharmaceutical industry trends, shaping the future of global healthcare in 2023 and beyond.

Virtual Meetings

This article is going to focus on the need for effective communication-building that HCPs require other than communicating with patients.

Technology

The rapid integration of artificial intelligence (AI) in the healthcare and pharmaceutical industry has garnered global attention thanks to how it is completely transforming the medical sector. 

Virtual Meetings

The global pandemic played an instrumental role in expediting digital trends in the pharmaceutical industry, effectively making in-person conferences, seminars, and conventions, redundant. This is why medical and pharma companies must keep up with modern digital trends or risk damaging their strategic relationships with their advisory teams.

Trends in Pharma

The harrowing effects of global warming and continuous climate change pose extraordinary risks to public health. What's ironic is the fact that health industries throughout the globe massively contribute to this crisis. Learn more about the role of Medical Affairs in cutting CO2 Emissions

Education

MSLs are now moving towards a virtual way of work. This article will teach how industries can train their MSL teams to perform efficiently, leveraging modern digital and virtual platforms.

Education

In recent years, technology has fundamentally changed how people interact. It is commendable that Continuing Medical Education (CME) continues to focus on ensuring that medical professionals have the right tools to provide high-quality treatment.

Trends in Pharma

The work of the pharmaceutical industry entails a lot of travelling. MphaR is developing different digital platforms to help pharmaceutical companies reduce unnecessary travelling for employees and HCPs.

Company Updates

In June, the Mphar team participated in the ASCO summit and the EHA congress representing MphaR. Our team was very excited to be part of these events and visit Chicago and Vienna.

Company Updates

We are excited to announce the VABP Color Customisation update. Now, our platform is fully customisable. You can choose a main and an accent color to make sure that every detail of your event suits your company branding.

Virtual Meetings

Working from home introduces new concerns, and one of which is managing virtual meetings online. If used appropriately, such virtual meetings may be considerably more accurate than conventional meetings. There are a few Dos and Don'ts to ensure a smoother transition from the hospital conference rooms to a virtual meeting session.

Virtual Meetings

While there are certain benefits to conducting a physical event, there is no match when it comes to the benefits of presenting a virtual event. In this article, we have collected some pros and cons of conducting an event in the online format.

Company Updates

Today, we want to continue improving the quality of interactions between HCPs. We are going further than ever before and giving our clients more opportunities for communication. We are excited to announce the VABP Multilingual release.

Virtual Meetings

Pharmaceutical companies should think about including online virtual meetings in their employees' retention and engagement programs. Several tips and tricks can facilitate interactive sessions that foster significant participation of their employees. Listed below are some of the techniques that can improve online engaging sessions.

Company Updates

In February, Natalia Denisova, PhD, Vice President, Head of Medical Affairs, and Sara Frau, PhD, Scientific Director Oncology, participated in the CAR-TCR event representing MphaR. Our team was very excited to be part of the CAR-TCR Summit in London.

Virtual Meetings

The healthcare industry implemented different techniques to make interactions between pharmaceutical companies, healthcare professionals, and general physicians. Icebreakers for virtual meetings make it easy to connect with simple activities to build team camaraderie.

Trends in Pharma

The four pillars holding the healthcare industry together include health services, pharmaceuticals, finances and medical devices. These provide a synergistic and holistic effort to bring about the best possible outcomes for patients in terms of quality of life and life expectancy, in general.

Trends in Pharma

Insights from KOLs who attend advisory board meetings organized by different pharma companies. An analysis of responses to our questionnaire allowed us to take a closer look at the disadvantages of face-to-face advisory boards and also to learn about KOLs preferences related to the meeting format.

Trends in Pharma

Pharmaceutical companies rely on annual advisory board meetings to strengthen relationships with KOLs. IThis article focuses on how Medical Affairs teams in the pharmaceutical industry have adapted to meet the challenges presented by this new environment.

Virtual Meetings

Medical affairs offer scientific support by communicating medical information to healthcare professionals (HCPs). The COVID-19 pandemic led to a decline in face-to-face (F2F) interactions and urged pharma professionals to alter their stances and adjust the medical affairs practice.